The strong performance of global equities continued in the first quarter, fueled, as it was in the fourth quarter, by progress on COVID-19 vaccination programs and the relaxation of pandemic-led restrictions in parts of the world. Due to an improving public health situation and the flood of easy money from unprecedented monetary and fiscal stimulus, many countries appear ready for a rapid economic recovery. But recovery expectations have investors bracing for inflation, leading to a spike in developed-market bond yields that spurred market volatility, though it did not halt investors’ enthusiasm for equities.
However, the bond selloff was accompanied by an equity rotation out of the “stay-at-home” companies that thrived during the downturn and into more economically sensitive sectors. Many cyclical and value-oriented businesses that we deem to be lower quality—which had previously been beaten down by the pandemic—fared well in the first quarter.
How did we do?
Performance has been presented for the A-Series Mawer Mutual Funds in Canadian dollars and calculated net of fees for the 3-month period of January 1 – March 31, 2021.
In terms of market performance, the big story of the quarter was rising inflation expectations and long-term bond yields. While most central banks are steadfast in their commitment to keeping short-term interest rates low, longer- term yields rose given the optimism around vaccine deployment, continued economic reopening, and fiscal stimulus. For balanced investors, the sharp rise in longer-term interest rates had the most direct impact on the portfolio’s bond component. Predictably, the backdrop resulted in negative fixed income returns.
Our equity portfolios delivered mostly positive returns but generally lagged their benchmarks in a continuation of the themes that drove relative performance in Q4. However, in a market driven by optimism about economic expansion, the procyclical Canadian dollar was one of the top performers globally, which dampened foreign equity returns in Canadian dollar terms.
Areas of strength during the quarter included dedicated exposure to small-cap stocks, as well as those elements of our portfolios that are more exposed to the reopening theme:
- Bank stocks performed strongly as rising interest rates and greater economic activity bode well for their future profitability, with TD, JPMorgan, Sweden’s Handelsbanken, and Singapore’s DBS bolstering portfolio returns.
- Other companies in our portfolios also benefit from higher interest rates, such as CME Group, the largest derivatives exchange in the world, given its interest rate franchise and higher investment returns from collateral.
- While energy exposure in our portfolios is limited, Suncor and Canadian Natural Resources figured prominently among our Canadian equity strategy’s top performers.
- Other companies that performed admirably during the quarter with more cyclical exposure included: door- lock manufacturer Assa Abloy, and Beijing Oriental Yuhong, the largest and most technologically advanced provider of building waterproofing materials in China.
By contrast, areas of relative weakness included:
- Given the procyclical backdrop, those “boring” businesses that we prize for their predictable, recurring revenue streams:
- our Japanese drug store holdings (Tsuruha, Kusuri no Aoki, Create SD),
- used heavy equipment auctioneer Ritchie Brothers, given the counter-cyclical nature of its business, and
- consumer staples companies like Nestlé.
- As hinted at above, a lesser exposure to what we deem to be tougher, less competitively advantaged business models such as energy, banks, and mining companies.
- While the rise in discount rates had the most direct impact on fixed income assets, equities are also sensitive to these changes, particularly those companies whose valuations are most dependent on cash flow projections further into the future. Many higher-growth companies fit this mould, including Canada’s Dye & Durham as well as Shopify and Amazon.
- These declines were further exacerbated when coupled with earnings releases or guidance that missed expectations. For example, SimCorp, a company that provides mission-critical software to investment management organizations (like Mawer), issued more conservative guidance with its most recent results which led to a selloff. Our investment thesis is indeed predicated on client and market share gains to justify its valuation, but we believe this is a short-term overreaction and have added to our position given a more reasonable valuation.
- And despite the overall optimism, negative developments impacted some of our holdings. Our investment thesis in Shanghai International Airport is based on long-term structural tailwinds around Chinese air travel, but also predicated on the idea that it is essentially a shopping mall with runways (or more cynically, a jail with retail stores!). The majority of revenue is derived from rental income and concession arrangements with duty free store tenants, and the airport’s pricing power is an important component to the thesis. During the quarter, we learned that the company’s latest contract negotiations with its retail partners will result in lower expected revenues over the next several years, highlighting that the degree of pricing power isn’t as strong as we initially thought. We reduced our position accordingly.
And now, after a full year of worrying about the destructive effects of COVID-19, investor psychology seems to be acutely focused on a return to “normal” in the months ahead. Indeed, the arrival of the COVID-19 vaccines was a meaningful turning point in the fight against the virus, and government and central bank intervention prevented a worst-case economic collapse. However, delays in global COVID-19 vaccination programs could lead to the spread of novel variants that force the economy to not operate at full capacity for a long time. And if governments and central banks don’t effectively navigate the tight rope to economic recovery, they risk spurring inflation or sabotaging still fragile economies. In our view, stock prices continue to reflect a degree of optimism that leaves them vulnerable to setbacks if investors’ expectations are not met.
We continue to be aware of the general top-down picture but evaluate every opportunity from a bottom-up perspective. As always, our focus remains on following our investment philosophy and looking at risk from an absolute sense—making sure that we do not impair clients’ capital. From Mawer’s perspective, combining a systematic and disciplined investment process with an unwavering focus on preserving clients’ capital remains a prudent approach for investors looking to protect and compound capital over long periods of time.
Non-performance related material in this document reflects the opinions of the writer, and does not reflect fact or predictions of actual events or impacts, and cannot be relied upon for investing purposes or as investment advice or guarantees of any kind.
Index returns are supplied by a third party—we believe the data to be accurate, however, cannot guarantee its accuracy.
This document is for information purposes only. Before investing, please consult the simplified prospectus, available at www.sedar.com, and the Fund Facts. Mutual funds are not guaranteed, their values change frequently, and past performance is not indicative of future performance. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. (Mutual fund securities are not covered by the Canada Deposit Insurance Corporation or by any other government deposit insurer. There can be no assurances that the fund will be able to maintain its net asset value per share at a constant amount or that the full amount of your investment in the fund will be returned to you.)
Performance returns for the Mawer Mutual Funds are calculated by Mawer Investment Management Ltd. These returns are historical simple returns for the 3 month, YTD and 1 year periods, and annualized compounded total returns for periods after 1 year. They include changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder that would have reduced returns.
This Mawer Quarterly includes certain statements that are “forward looking statements”. All statements, other than statements of historical fact, included in this report that address activities, events or developments that the portfolio advisor, Mawer Investment Management Ltd., expects or anticipates will or may occur in the future, including such things as anticipated ﬁnancial performance, are forward looking statements. The words “may”, “could”, “would”, “should”, “believe”, “plan”, “anticipate”, “expect”, “intend”, “forecast”, “objective” and similar expressions are intended to identify forward looking statements. These forward looking statements are subject to various risks and uncertainties, including the risks described in the Simpliﬁed Prospectus of the Fund, uncertainties and assumptions about the Fund, capital markets and economic factors, which could cause actual ﬁnancial performance and expectations to differ materially from the anticipated performance or other expectations expressed. Economic factors include, but are not limited to, general economic, political and market factors in North America and internationally, interest and foreign exchange rates, global equity and capital markets, business competition, technological change, changes in government regulations, unexpected judicial or regulatory proceedings, and catastrophic events.
All opinions contained in forward looking statements are subject to change without notice and are provided in good faith but without legal responsibility. The portfolio advisor has no speciﬁc intention of updating any forward looking statements whether as a result of new information, future events or otherwise, except as required by securities legislation. Certain research and information about speciﬁc holdings in the Fund, including any opinion, is based upon various sources believed to be reliable, but it cannot be guaranteed to be current, accurate or complete. It is for information only, and is subject to change without notice.
The MSCI information may only be used for your internal use, may not be reproduced or disseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (www.msci.com)
London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2021. FTSE Russell is a trading name of certain of the LSE Group companies. FTSE® is a trade mark(s) of the relevant LSE Group companies and is/are used by any other LSE Group company under license. “TMX®” is a trade mark of TSX, Inc. and used by the LSE Group under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.